The iwCLL Biennial Meeting focuses solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, it is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts – from laboratory-based research to the clinic – in the pathobiology and treatment of these blood cancers. The Biennial Meeting which attracts around 1400 delegates from over 40 countries is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders.
The iwCLL is now actively seeking applications from parties interested in hosting the 2027 Biennial Meeting.
Prospective hosts are invited to read the Information and Instructions to Host the 2027 Biennial Meeting and Appendices.
Applications should be submitted by email to the iwCLL Executive Office ([email protected]) by
22 December 2023 at 17:00 CEST. This is a firm deadline and no extensions to the deadline will be given.
iwCLL alternates the Biennial Meeting location between Europe and USA.
iwCLL does not accept applications from potential hosts from remote areas of the world. This is due to difficulties in securing industry support, flight costs for the major scientific contributors and the costs to delegates attending.
Any questions relating to the application process should be directed to the iwCLL Executive Office [email protected].